Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS: FRTX · Delayed Price · USD
0.900
0.00 (0.00%)
Apr 17, 2024, 3:13 PM EDT - Market open
Fresh Tracks Therapeutics Market Cap
Fresh Tracks Therapeutics has a market cap or net worth of $5.38 million as of April 18, 2024. Its market cap has increased by 14.38% in one year.
Market Cap
5.38M
Enterprise Value
-5.49M
1-Year Change
14.38%
Ranking
n/a
Category
Stock Price
$0.90
Market Cap Chart
Since December 1, 1998, Fresh Tracks Therapeutics's market cap has decreased from $248.20M to $5.38M, a decrease of -97.83%. That is a compound annual growth rate of -14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2023 | 4.70M | -2.08% |
| Dec 15, 2023 | 4.80M | -5.88% |
| Dec 14, 2023 | 5.10M | - |
| Dec 13, 2023 | 5.10M | 2.00% |
| Dec 12, 2023 | 5.00M | -1.96% |
| Dec 11, 2023 | 5.10M | -7.27% |
| Dec 8, 2023 | 5.50M | - |
| Dec 7, 2023 | 5.50M | 3.77% |
| Dec 6, 2023 | 5.30M | 3.92% |
| Dec 5, 2023 | 5.10M | -1.92% |
| Dec 4, 2023 | 5.20M | 6.12% |
| Dec 1, 2023 | 4.90M | -2.00% |
| Nov 30, 2023 | 5.00M | 4.17% |
| Nov 29, 2023 | 4.80M | 2.13% |
| Nov 28, 2023 | 4.70M | 2.17% |
| Nov 27, 2023 | 4.60M | -2.13% |
| Nov 24, 2023 | 4.70M | 2.17% |
| Nov 22, 2023 | 4.60M | -2.13% |
| Nov 21, 2023 | 4.70M | - |
| Nov 20, 2023 | 4.70M | -6.00% |
| Nov 17, 2023 | 5.00M | -5.66% |
| Nov 16, 2023 | 5.30M | -1.85% |
| Nov 15, 2023 | 5.40M | - |
| Nov 14, 2023 | 5.40M | -1.82% |
| Nov 13, 2023 | 5.50M | - |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 713.81B |
| Novo Nordisk | 564.13B |
| UnitedHealth Group | 441.60B |
| Johnson & Johnson | 348.72B |
| Merck & Co. | 317.52B |
| AbbVie | 290.83B |
| AstraZeneca | 212.43B |
| Thermo Fisher | 208.89B |